Premier 26 Immunotherapy Biotech Firms of 2021
Premier 26 Immunotherapy Biotech Firms of 2021
The immunotherapy biotech industry is pioneering groundbreaking advancements in cancer treatments. This sector includes companies like Kite Pharma, Genmab, and Adaptimmune who engineer innovative solutions from our body's immune system to fight cancer. They leverage advanced technologies in various forms of immunotherapies, such as genetically modified T cell therapy and antibody technology platforms. These therapies could potentially revolutionize the way cancer is treated, making treatments more effective and less detrimental to patients' overall health. As advancements continue, this industry aims to provide more efficient and sustainable cancer treatments, fueling hopes for a cancer-free future.
Top 26 Immunotherapy Biotech Companies
1. Kite Pharma
- Website: kitepharma.com
- Headquarters: Santa Monica, California, United States
- Founded: 2009
- Headcount: 1001-5000
- Latest funding type: Acquired
Kite Pharma is a leading company in cancer immunotherapy, specializing in engineered T cell therapy. They aim to revolutionize cancer treatment by utilizing genetically modified immune cells to target tumors. Kite offers potentially lifesaving therapies for patients with hematologic cancers and solid tumors, including allogeneic therapies. With a focus on curative treatments, Kite is dedicated to bringing innovative solutions to those in need.
2. Genmab
- Website: genmab.com
- Headquarters: Copenhagen V, Hovedstaden, Denmark
- Founded: 1999
- Headcount: 1001-5000
- Latest funding type: Ipo
Genmab is a pharmaceutical company specializing in transforming cancer treatment through innovative medicine. They leverage antibody technology platforms to discover and develop the best possible antibody products. Their focus on harnessing the power of the immune system to fight diseases has the potential to revolutionize cancer treatment.
3. Adaptimmune
- Website: adaptimmune.com
- Headquarters: Abingdon, Oxfordshire, United States
- Founded: 2008
- Headcount: 201-500
- Latest funding type: Post Ipo Equity
Adaptimmune is a company that designs and delivers cell therapies to transform the lives of people with cancer. They focus on improving outcomes for cancer patients through immunotherapy. Their resources and clinical trials are available to both patients and their families.
4. SOTIO Biotech
- Website: sotio.com
- Headquarters: Prague, Hlavni Mesto Praha, Czechia
- Founded: 2010
- Headcount: 201-500
- Latest funding type: Series Unknown
SOTIO® Biotech is a company focused on developing potent immunotherapies for cancer patients.
5. AvenCell
- Website: avencell.com
- Headquarters: Cambridge, Massachusetts, United States
- Headcount: 51-200
AvenCell Therapeutics is a biotech company specializing in next generation immunotherapies for hard-to-treat cancers. Their innovative technology addresses the limitations of current T cell-based immunotherapies, offering powerful, targeted, and safe treatments. With a focus on patient outcomes, AvenCell aims to transform the future of cancer immunotherapies.
6. HOOKIPA Pharma Inc.
- Website: hookipapharma.com
- Headquarters: New York, New York, United States
- Founded: 2011
- Headcount: 51-200
- Latest funding type: Post Ipo Equity
HOOKIPA Pharma is a biotech company specializing in immunotherapy. They develop and engineer arenaviral therapeutics to mobilize the body's natural infection killers, such as T cells and antibodies, to fight and prevent serious diseases like cancer and infectious diseases.
7. Hummingbird Bioscience
- Website: hummingbirdbioscience.com
- Headquarters: Singapore, North Region, Singapore
- Founded: 2015
- Headcount: 51-200
- Latest funding type: Series C
Hummingbird Bioscience is a therapeutic antibody discovery company that specializes in the development of next-generation cancer treatments. They offer innovative solutions that target specific immune pathways to combat various cancers. With a strong focus on research and development, Hummingbird Bioscience aims to revolutionize cancer treatment and improve patient outcomes.
8. Bolt Biotherapeutics, Inc.
- Website: boltbio.com
- Headquarters: Redwood City, California, United States
- Founded: 2015
- Headcount: 51-200
- Latest funding type: Post Ipo Equity
Bolt Biotherapeutics is a biotech company focused on developing immune-stimulating, myeloid-engaging therapeutics for the treatment of solid tumors, including HER2-low tumors. Leveraging their Boltbody™ ISAC approach and expertise in myeloid biology, they are dedicated to delivering transformative treatments for cancer patients with unmet medical needs.
9. F-star Therapeutics, Inc.
- Website: f-star.com
- Headquarters: Cambridge, Cambridgeshire, United Kingdom
- Founded: 2006
- Headcount: 51-200
- Latest funding type: Acquired
F-star is a clinical stage biotech company focused on developing next generation immunotherapies for cancer and other serious diseases. They are working on promising immuno-oncology targets in drug development and aim to provide life-extending immunotherapies for patients with limited treatment options.
10. Synthekine
- Website: synthekine.com
- Headquarters: Menlo Park, California, United States
- Founded: 2018
- Headcount: 51-200
- Latest funding type: Series C
Synthekine is a company specializing in protein engineering platforms for developing selective immunotherapies against cancers and inflammatory diseases. They aim to address the limitations of current cytokine therapeutics by using three distinct protein engineering platforms.
11. Atreca, Inc.
- Website: atreca.com
- Headquarters: South San Francisco, California, United States
- Founded: 2011
- Headcount: 51-200
- Latest funding type: Post Ipo Equity
Atreca is a biotech company specializing in the discovery and development of antibody-based cancer immunotherapeutics. They utilize a unique approach and advanced analysis of the immune response through their discovery platform.
12. Adicet Bio, Inc
- Website: adicetbio.com
- Headquarters: Redwood City, California, United States
- Founded: 2014
- Headcount: 51-200
- Latest funding type: Post Ipo Equity
Adicet Bio is a biotechnology company specializing in the development of allogeneic, off-the-shelf genetically modified gamma delta T cells for targeted cancer therapy.
13. Precision BioSciences, Inc.
- Website: precisionbiosciences.com
- Headquarters: Durham, North Carolina, United States
- Founded: 2006
- Headcount: 201-500
- Latest funding type: Post Ipo Equity
Precision BioSciences is a company dedicated to in vivo gene editing therapies. They specialize in permanently correcting genetic diseases through their ARCUS platform and CAR T immunotherapy. Precision BioSciences collaborates with healthcare companies and researchers to develop potentially curative treatments. They offer expertise in precision medicine and have a strong skill set within the genome editing industry.
14. Steba Biotech Ltd.
- Website: stebabiotech.com
- Headquarters: New York, New York, Israel
- Founded: 1996
- Headcount: 51-200
Steba Biotech is a biotechnology company at the forefront of the industry, developing precise and effective therapeutic solutions for cancer patients. Their novel Oncology technology platform, ImPACT, offers surgery-like efficacy for localized and metastatic solid tumors. This technology allows patients to confidently face the challenges of cancer while maintaining their quality of life.
15. Neogene Therapeutics
- Website: neogene.com
- Headquarters: Amsterdam, North Holland, Netherlands
- Founded: 2018
- Headcount: 11-50
- Latest funding type: Acquired
Neogene Therapeutics is a pioneering company that specializes in developing next-generation, neoantigen-targeting engineered T cell receptor therapies for solid cancers.
16. Tmunity Therapeutics Incorporated
- Website: tmunity.com
- Headquarters: Philadelphia, Pennsylvania, United States
- Founded: 2015
- Headcount: 51-200
- Latest funding type: Acquired
Tmunity is a biotech company focused on developing highly engineered CAR T cell therapies for cancer patients. Their proprietary modular engineering approach addresses the complexities of tumor biology and the immunosuppressive tumor microenvironment, aiming to deliver cures for various types of cancer.
17. Aurigene Discovery Technologies
- Website: aurigene.com
- Headquarters: Bangalore, Karnataka, India
- Founded: 2002
- Headcount: 501-1000
Aurigene is a clinical stage biotech company dedicated to discovering and developing novel and effective therapeutics for cancer treatment. With a focus on innovative therapies, Aurigene leverages its deep expertise in oncology research and collaboration with global partners to benefit cancer patients everywhere.
18. Candel Therapeutics
- Website: candeltx.com
- Headquarters: Needham, Massachusetts, United States
- Founded: 1999
- Headcount: 51-200
- Latest funding type: Post Ipo Debt
Candeltx.com is a company that specializes in therapeutics and oncology research. They offer innovative treatments and solutions for various types of cancer. With a focus on research and development, the company aims to improve patient outcomes and revolutionize the field of oncology.
19. Surface Oncology Inc.
- Website: surfaceoncology.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2014
- Headcount: 51-200
- Latest funding type: Post Ipo Equity
Surface Oncology is a company focused on limitless innovation for people with cancer. They develop breakthrough pipeline and programs in the field of oncology, aiming to improve the lives of cancer patients. Surface Oncology offers a range of scientific and medical solutions to combat cancer.
20. Dragonfly Therapeutics, Inc.
- Website: dragonflytx.com
- Headquarters: Waltham, Massachusetts, United States
- Founded: 2015
- Headcount: 51-200
- Latest funding type: Series Unknown
Dragonfly Therapeutics is a clinical-stage biotech company that rapidly develops drugs in collaboration with pharma partners. They focus on expanding fields such as oncology, immunology, neuromuscular disease, virology, and more.
21. Janux Therapeutics
- Website: januxrx.com
- Headquarters: San Diego, California, United States
- Founded: 2017
- Headcount: 11-50
- Latest funding type: Ipo
Janux Therapeutics is a company that is developing tumor-activated immunotherapies precision-engineered to transform the lives of patients so they can focus on what counts.
22. Gradalis, Inc.
- Website: gradalisinc.com
- Headquarters: Carrollton, Texas, United States
- Founded: 2003
- Headcount: 11-50
- Latest funding type: Series Unknown
Gradalis is a company developing Vigil®, a personalized cancer immunotherapy for various solid tumor types, including ovarian and breast cancer. They offer unique treatment solutions through their Vigil Platform.
23. Innovative Cellular Therapeutics (ICT)
- Website: ictbio.com
- Headquarters: Rockville, Maryland, United States
- Founded: 2009
- Headcount: 51-200
Innovative Cellular Therapeutics (ICT) is a company focused on the development and commercialization of innovative cellular therapies for the treatment of cancer. Their offerings include chimeric antigen receptor (CAR) T-cell therapy for both liquid and solid tumors.
24. Triumvira Immunologics, Inc.
- Website: triumvira.com
- Headquarters: Austin, Texas, United States
- Founded: 2015
- Headcount: 11-50
Triumvira Immunologics is a company that specializes in developing and offering innovative T cell therapies for the treatment of life-threatening cancers. Their TAC technology enables T cells to target cancer cells using different antigens, providing broad applicability in both liquid and solid tumors.
25. Amal Therapeutics
- Website: amaltherapeutics.com
- Headquarters: Geneva, Geneve, Switzerland
- Founded: 2012
- Headcount: 11-50
- Latest funding type: Acquired
AMAL Therapeutics is a company dedicated to transforming the prospects of cancer patients. They focus on the development of viable effective cancer therapies and utilize their unique proprietary protein-based immunization platform, KISIMA®, to discover and develop therapeutic vaccines. Their most advanced asset is ATP128, a therapeutic vaccine for the treatment of metastatic colorectal cancers.
26. OncoC4, Inc.
- Website: oncoc4.com
- Headquarters: Rockville, Maryland, United States
- Founded: 2020
- Headcount: 11-50
OncoC4 is a clinical-stage biopharmaceutical company based in Rockville, Maryland. They specialize in the discovery and development of novel biologicals for cancer treatment. Their pipeline consists of best-in-class and first-in-class immunotherapy products that target cancer evasion of adaptive and innate immunity.
Want to find more immunotherapy biotech companies?
If you want to find more companies that specialize in cancer-targeting immunotherapy treatments you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.
With Inven you'll also get to know the company's:
- Ownership: Which of these are private equity backed? Which are family-owned?
- Contact data: Who are the owners and CEO's? What are their emails and phone numbers?
- Financials: How do these companies perform financially? What are their revenues and profit margins?
...and a lot more!
